Works matching IS 10584838 AND DT 2019 AND VI 68 AND IP 4

Results: 31
    1

    Saddle Nose Deformity in an Immunosuppressed Patient.

    Published in:
    2019
    By:
    • Anjan, Shweta;
    • Morillas, Jose;
    • Simkins, Jacques;
    • Martinez, Octavio V;
    • Holung, Michelle;
    • Prado, Clara;
    • Jimenez, Antonio;
    • Lekakis, Lazaros J;
    • Komanduri, Krishna;
    • Morris, Michele I;
    • Camargo, Jose F
    Publication type:
    Case Study
    2
    3
    4

    In the Literature.

    Published in:
    Clinical Infectious Diseases, 2019, v. 68, n. 4, p. iii, doi. 10.1093/cid/ciz028
    Publication type:
    Article
    5

    Bezlotoxumab.

    Published in:
    Clinical Infectious Diseases, 2019, v. 68, n. 4, p. 699, doi. 10.1093/cid/ciy577
    By:
    • Johnson, Stuart;
    • Gerding, Dale N
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13

    News.

    Published in:
    Clinical Infectious Diseases, 2019, v. 68, n. 4, p. i, doi. 10.1093/cid/ciy1016
    Publication type:
    Article
    14
    15
    16

    High Number of Potential Transmitters Revealed in a Population-based Systematic Hepatitis C Virus RNA Screening Among Human Immunodeficiency Virus-infected Men Who Have Sex With Men.

    Published in:
    Clinical Infectious Diseases, 2019, v. 68, n. 4, p. 561, doi. 10.1093/cid/ciy547
    By:
    • Braun, Dominique L;
    • Hampel, Benjamin;
    • Martin, Eileen;
    • Kouyos, Roger;
    • Kusejko, Katharina;
    • Grube, Christina;
    • Flepp, Markus;
    • Stöckle, Marcel;
    • Conen, Anna;
    • Béguelin, Charles;
    • Schmid, Patrick;
    • Delaloye, Julie;
    • Rougemont, Mathieu;
    • Bernasconi, Enos;
    • Rauch, Andri;
    • Günthard, Huldrych F;
    • Böni, Jürg;
    • Fehr, Jan S;
    • Study, Swiss HIV Cohort
    Publication type:
    Article
    17

    Impact of Routine Cryptococcal Antigen Screening and Targeted Preemptive Fluconazole Therapy in Antiretroviral-naive Human Immunodeficiency Virus–infected Adults With CD4 Cell Counts <100/μL: A Systematic Review and Meta-analysis.

    Published in:
    Clinical Infectious Diseases, 2019, v. 68, n. 4, p. 688, doi. 10.1093/cid/ciy567
    By:
    • Temfack, Elvis;
    • Bigna, Jean Joel;
    • Luma, Henry N;
    • Spijker, Rene;
    • Meintjes, Graeme;
    • Jarvis, Joseph N;
    • Dromer, Françoise;
    • Harrison, Thomas;
    • Cohen, Jérémie F;
    • Lortholary, Olivier
    Publication type:
    Article
    18

    Immediate Versus Deferred Switching From a Boosted Protease Inhibitor–based Regimen to a Dolutegravir-based Regimen in Virologically Suppressed Patients With High Cardiovascular Risk or Age ≥50 Years: Final 96-Week Results of the NEAT022 Study

    Published in:
    Clinical Infectious Diseases, 2019, v. 68, n. 4, p. 597, doi. 10.1093/cid/ciy505
    By:
    • Gatell, José M;
    • Assoumou, Lambert;
    • Moyle, Graeme;
    • Waters, Laura;
    • Johnson, Margaret;
    • Domingo, Pere;
    • Fox, Julie;
    • Martinez, Esteban;
    • Stellbrink, Hans-Jürgen;
    • Guaraldi, Giovanni;
    • Masia, Mar;
    • Gompels, Mark;
    • Wit, Stephane De;
    • Florence, Eric;
    • Esser, Stefan;
    • Raffi, François;
    • Stephan, Christoph;
    • Rockstroh, Juergen;
    • Giacomelli, Andrea;
    • Vera, Jaime
    Publication type:
    Article
    19

    Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus–1 Infection: Week 48 Results of the DRIVE-AHEAD Trial.

    Published in:
    Clinical Infectious Diseases, 2019, v. 68, n. 4, p. 535, doi. 10.1093/cid/ciy540
    By:
    • Orkin, Chloe;
    • Squires, Kathleen E;
    • Molina, Jean-Michel;
    • Sax, Paul E;
    • Wong, Wing-Wai;
    • Sussmann, Otto;
    • Kaplan, Richard;
    • Lupinacci, Lisa;
    • Rodgers, Anthony;
    • Xu, Xia;
    • Lin, Gina;
    • Kumar, Sushma;
    • Sklar, Peter;
    • Nguyen, Bach-Yen;
    • Hanna, George J;
    • Hwang, Carey;
    • Martin, Elizabeth A;
    • Group, DRIVE-AHEAD Study
    Publication type:
    Article
    20

    High Cure Rates With Grazoprevir-Elbasvir With or Without Ribavirin Guided by Genotypic Resistance Testing Among Human Immunodeficiency Virus/Hepatitis C Virus–coinfected Men Who Have Sex With Men.

    Published in:
    Clinical Infectious Diseases, 2019, v. 68, n. 4, p. 569, doi. 10.1093/cid/ciy547
    By:
    • Braun, Dominique L;
    • Hampel, Benjamin;
    • Kouyos, Roger;
    • Nguyen, Huyen;
    • Shah, Cyril;
    • Flepp, Markus;
    • Stöckle, Marcel;
    • Conen, Anna;
    • Béguelin, Charles;
    • Künzler-Heule, Patrizia;
    • Nicca, Dunja;
    • Schmid, Patrick;
    • Delaloye, Julie;
    • Rougemont, Mathieu;
    • Bernasconi, Enos;
    • Rauch, Andri;
    • Günthard, Huldrych F;
    • Böni, Jürg;
    • Fehr, Jan S;
    • Study, Swiss HIV Cohort
    Publication type:
    Article
    21
    22
    23
    24

    Accuracy and Operational Characteristics of Xpert Human Immunodeficiency Virus Point-of-Care Testing at Birth and Until Week 6 in Human Immunodeficiency Virus–exposed Neonates in Tanzania.

    Published in:
    Clinical Infectious Diseases, 2019, v. 68, n. 4, p. 615, doi. 10.1093/cid/ciy538
    By:
    • Sabi, Issa;
    • Mahiga, Hellen;
    • Mgaya, Jimson;
    • Geisenberger, Otto;
    • Kastner, Sabine;
    • Olomi, Willyhelmina;
    • Saathoff, Elmar;
    • Njovu, Lilian;
    • Lueer, Cornelia;
    • France, John;
    • Maboko, Leonard;
    • Ntinginya, Nyanda Elias;
    • Hoelscher, Michael;
    • Kroidl, Arne
    Publication type:
    Article
    25

    Cover.

    Published in:
    Clinical Infectious Diseases, 2019, v. 68, n. 4, p. NP, doi. 10.1093/cid/ciy1059
    Publication type:
    Article
    26

    Cost-effectiveness and Cost-utility of the Adherence Improving Self-management Strategy in Human Immunodeficiency Virus Care: A Trial-based Economic Evaluation.

    Published in:
    Clinical Infectious Diseases, 2019, v. 68, n. 4, p. 658, doi. 10.1093/cid/ciy553
    By:
    • Wijnen, Ben F M;
    • Oberjé, Edwin J M;
    • Evers, Silvia M A A;
    • Prins, Jan M;
    • Nobel, Hans-Erik;
    • Nieuwkoop, Cees van;
    • Veenstra, Jan;
    • Pijnappel, Frank J;
    • Kroon, Frank P;
    • Zonneveld, Laura van;
    • Hulzen, Astrid G W van;
    • Broekhuizen, Marjolein van;
    • Bruin, Marijn de
    Publication type:
    Article
    27
    28
    29

    Cessation of Cigarette Smoking and the Impact on Cancer Incidence in Human Immunodeficiency Virus–infected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study.

    Published in:
    Clinical Infectious Diseases, 2019, v. 68, n. 4, p. 650, doi. 10.1093/cid/ciy508
    By:
    • Shepherd, Leah;
    • Ryom, Lene;
    • Law, Matthew;
    • Petoumenos, Kathy;
    • Hatleberg, Camilla Ingrid;
    • Monforte, Antonella d'Arminio;
    • Sabin, Caroline;
    • Bower, Mark;
    • Bonnet, Fabrice;
    • Reiss, Peter;
    • Wit, Stephane de;
    • Pradier, Christian;
    • Weber, Rainer;
    • el-Sadr, Wafaa;
    • Lundgren, Jens;
    • Mocroft, Amanda;
    • Group, Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study
    Publication type:
    Article
    30

    Autologous Adoptive T-cell Therapy for Recurrent or Drug-resistant Cytomegalovirus Complications in Solid Organ Transplant Recipients: A Single-arm Open-label Phase I Clinical Trial.

    Published in:
    Clinical Infectious Diseases, 2019, v. 68, n. 4, p. 632, doi. 10.1093/cid/ciy549
    By:
    • Smith, Corey;
    • Beagley, Leone;
    • Rehan, Sweera;
    • Neller, Michelle A;
    • Crooks, Pauline;
    • Solomon, Matthew;
    • Holmes-Liew, Chien-Li;
    • Holmes, Mark;
    • McKenzie, Scott C;
    • Hopkins, Peter;
    • Campbell, Scott;
    • Francis, Ross S;
    • Chambers, Daniel C;
    • Khanna, Rajiv
    Publication type:
    Article
    31